Diem Vuong1, Stephanie Tanadini-Lang1, Ze Wu1, Robert Marks1, Jan Unkelbach1, Sven Hillinger2, Eric Innocents Eboulet3, Sandra Thierstein3, Solange Peters4, Miklos Pless5, Matthias Guckenberger1, Marta Bogowicz1. 1. Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. 2. Department of Thoracic Surgery, University Hospital Zurich and University of Zurich, Zurich, Switzerland. 3. Department of Clinical Trial Management, Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland. 4. Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. 5. Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Abstract
INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows to identify the spatial-anatomical locations responsible for signature activation based on local radiomics. The feasibility of this technique will be studied for histological subtype differentiation (adenocarcinoma versus squamous cell carcinoma) in non-small cell lung cancer (NSCLC) using computed tomography (CT) radiomics. MATERIALS AND METHODS: Pre-treatment CT scans were collected from a multi-centric Swiss trial (training, n=73, IIIA/N2 NSCLC, SAKK 16/00) and an independent cohort (validation, n=32, IIIA/N2/IIIB NSCLC). Based on the gross tumor volume (GTV), four peritumoral region of interests (ROI) were defined: lung_exterior (expansion into the lung), iso_exterior (expansion into lung and soft tissue), gradient (GTV border region), GTV+Rim (GTV and iso_exterior). For each ROI, 154 radiomic features were extracted using an in-house developed software implementation (Z-Rad, Python v2.7.14). Features robust against delineation variability served as an input for a multivariate logistic regression analysis. Model performance was quantified using the area under the receiver operating characteristic curve (AUC) and verified using five-fold cross validation and internal validation. Local radiomic features were extracted from the GTV+Rim ROI using non-overlapping 3x3x3 voxel patches previously marked as GTV or rim. A binary activation map was created for each patient using the median global feature value from the training. The ratios of activated/non-activated patches of GTV and rim regions were compared between histological subtypes (Wilcoxon test). RESULTS: Iso_exterior, gradient, GTV+Rim showed good performances for histological subtype prediction (AUCtraining=0.68-0.72 and AUCvalidation=0.73-0.74) whereas GTV and lung_exterior models failed validation. GTV+Rim model feature activation maps showed that local texture feature distribution differed significantly between histological subtypes in the rim (p=0.0481) but not in the GTV (p=0.461). CONCLUSION: In this exploratory study, radiomics-based prediction of NSCLC histological subtypes was predominantly based on the peritumoral region indicating that radiomics activation maps can be useful for tracing back the spatial location of regions responsible for signature activation.
INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows to identify the spatial-anatomical locations responsible for signature activation based on local radiomics. The feasibility of this technique will be studied for histological subtype differentiation (adenocarcinoma versus squamous cell carcinoma) in non-small cell lung cancer (NSCLC) using computed tomography (CT) radiomics. MATERIALS AND METHODS: Pre-treatment CT scans were collected from a multi-centric Swiss trial (training, n=73, IIIA/N2 NSCLC, SAKK 16/00) and an independent cohort (validation, n=32, IIIA/N2/IIIB NSCLC). Based on the gross tumor volume (GTV), four peritumoral region of interests (ROI) were defined: lung_exterior (expansion into the lung), iso_exterior (expansion into lung and soft tissue), gradient (GTV border region), GTV+Rim (GTV and iso_exterior). For each ROI, 154 radiomic features were extracted using an in-house developed software implementation (Z-Rad, Python v2.7.14). Features robust against delineation variability served as an input for a multivariate logistic regression analysis. Model performance was quantified using the area under the receiver operating characteristic curve (AUC) and verified using five-fold cross validation and internal validation. Local radiomic features were extracted from the GTV+Rim ROI using non-overlapping 3x3x3 voxel patches previously marked as GTV or rim. A binary activation map was created for each patient using the median global feature value from the training. The ratios of activated/non-activated patches of GTV and rim regions were compared between histological subtypes (Wilcoxon test). RESULTS: Iso_exterior, gradient, GTV+Rim showed good performances for histological subtype prediction (AUCtraining=0.68-0.72 and AUCvalidation=0.73-0.74) whereas GTV and lung_exterior models failed validation. GTV+Rim model feature activation maps showed that local texture feature distribution differed significantly between histological subtypes in the rim (p=0.0481) but not in the GTV (p=0.461). CONCLUSION: In this exploratory study, radiomics-based prediction of NSCLC histological subtypes was predominantly based on the peritumoral region indicating that radiomics activation maps can be useful for tracing back the spatial location of regions responsible for signature activation.
Authors: Matea Pavic; Marta Bogowicz; Xaver Würms; Stefan Glatz; Tobias Finazzi; Oliver Riesterer; Johannes Roesch; Leonie Rudofsky; Martina Friess; Patrick Veit-Haibach; Martin Huellner; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Matthias Guckenberger; Stephanie Tanadini-Lang Journal: Acta Oncol Date: 2018-03-07 Impact factor: 4.089
Authors: Diem Vuong; Marta Bogowicz; Sarah Denzler; Carol Oliveira; Robert Foerster; Florian Amstutz; Hubert S Gabryś; Jan Unkelbach; Sven Hillinger; Sandra Thierstein; Alexandros Xyrafas; Solange Peters; Miklos Pless; Matthias Guckenberger; Stephanie Tanadini-Lang Journal: Med Phys Date: 2020-07-13 Impact factor: 4.071
Authors: Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck Journal: Radiology Date: 2020-03-10 Impact factor: 29.146
Authors: Weimiao Wu; Chintan Parmar; Patrick Grossmann; John Quackenbush; Philippe Lambin; Johan Bussink; Raymond Mak; Hugo J W L Aerts Journal: Front Oncol Date: 2016-03-30 Impact factor: 6.244
Authors: Subba R Digumarthy; Atul M Padole; Roberto Lo Gullo; Lecia V Sequist; Mannudeep K Kalra Journal: Medicine (Baltimore) Date: 2019-01 Impact factor: 1.889
Authors: Anna-Katharina Meißner; Robin Gutsche; Norbert Galldiks; Martin Kocher; Stephanie T Jünger; Marie-Lisa Eich; Manuel Montesinos-Rongen; Anna Brunn; Martina Deckert; Christina Wendl; Wolfgang Dietmaier; Roland Goldbrunner; Maximilian I Ruge; Cornelia Mauch; Nils-Ole Schmidt; Martin Proescholdt; Stefan Grau; Philipp Lohmann Journal: Neuro Oncol Date: 2022-08-01 Impact factor: 13.029